One day after the federal health authorities removed price regulations on medicines, the Drug Regulatory Authority of Pakistan (DRAP) announced a hike in the prices of 146 medicines listed as…
Drap
-
-
There is no ban on the import of any drug from India under the prevailing Import Policy Order 2022 and common people, as well as hospitals, can import essential drugs,…
-
The Drug Regulatory Authority (DRAP) issued a notification regarding an increase in the prices of medicines on Friday. According to the notification, the prices of life-saving medicines rose by 14%…
-
Announcing a countrywide crackdown against those involved in producing and spreading spurious and counterfeit medicines from today (Tuesday), Federal Health Minister Abdul Qadir Patel on Monday claimed that there was no shortage…
-
Special Assistant to Prime Minister (SAPM) on health Dr. Faisal Sultan said Drug Regulatory Authority of Pakistan (DRAP) should ensure availability of quality medicines on affordable prices to people, but…
-
Supreme Court of Pakistan (SCP) on Wednesday ordered Ministry of Industries and Production to fix the price of oxygen cylinders within two days. During the hearing of suo moto notice…
-
The Drug Regulatory Authority of Pakistan (DRAP) has, on Sunday taken charge of irregular drug-prices on which hoarding and profiteering was being carried out across the nation. The federal drug…
-
Shafaqna Pakistan: The Pakistan Atomic Energy Commission (PAEC) has introduced ‘i-Live’, the first ICU ventilator produced with national resources in the wake of the coronavirus pandemic. The Drug Regulatory Authority…
-
On Thursday, the Sindh High Court (SHC) allowed the firm, which had imported Russia’s Sputnik-V coronavirus vaccine, to sell it. The Drug Regulatory Authority of Pakistan (DRAP) submitted its reply…
-
Shafaqna Pakistan: The Drug Regulatory Authority of Pakistan (DRAP) has approved China’s CanSinoBio Covid-19 vaccine for emergency use in Pakistan, Dunya News reported. According to sources, Phase-III clinical trials of…
-
Shafaqna Pakistan: Drug Regulatory Authority of Pakistan’s (DRAP) Pakistan National Pharmacovigilance Centre (PNPC) in collaboration with the World Health Organization (WHO) have planned to arrange a day-long training on ‘reporting…
-
Shafaqna Pakistan: The Drug Regulatory Authority of Pakistan (DRAP) has approved the Russian anti-coronavirus vaccine Gam-COVID-Vac, also known as Sputnik V, for emergency use. According to details, the registration board…
-
Special Assistant on National Health Services, Regulations and Coordination Dr Faisal Sultan on Wednesday said that 1 million doses of coronavirus vaccine will be available in Pakistan in March. Addressing…
-
Other News
Sindh to establish vaccine fund as Centre delays getting Covid-19 vaccine, says Azra Pechuho
The Sindh government has decided to establish a ‘Covid-19 vaccine procurement fund’ with an initial capital of Rs1.5 billion for the procurement of vaccine for its frontline healthcare workers and…
-
Shafaqna Pakistan: AstraZeneca’s COVID-19 vaccine has been approved for emergency use in Pakistan, the health minister said on Saturday, making it the first coronavirus vaccine to get the green light…
-
The Lahore High Court (LHC) on Wednesday directed the Drug Regulatory Authority of Pakistan (DRAP) to furnish the record pertaining to the recent hike in prices of medicines. A counsel…
-
Condemning the government’s notification allowing an increase in prices of 94 lifesaving drugs, PPP leader and Senator Sherry Rehman pointed out that while other countries are making lifesaving drugs free…
-
Drug Regulatory Authority of Pakistan (DRAP) has issued notification of increase in prices of 94 medicines including medicines used for fever, headache, heart disease, malaria, diabetes, sore throat and flu.…
-
While the Drug Regulatory Authority of Pakistan (Drap) is solely responsible for regulating the pharmaceutical industry, senior government officials have raised alarm over violation of the Drug Act of 1976…
-
Up to 260 per cent increase in prices of medicines has compelled a major segment of patients to reduce drug dosage or discontinue treatment, while leading pharmaceutical manufactures believe the…